|
Volumn 4, Issue 4, 2002, Pages 268-271
|
Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases
a a |
Author keywords
Autoimmune disease; Immunosuppression; Stem cell; Transplantation
|
Indexed keywords
DISEASES;
PATHOLOGY;
PHYSIOLOGY;
TRANSPLANTATION (SURGICAL);
STEM CELL;
BIOMEDICAL ENGINEERING;
CAMPATH G MONOCLONAL ANTIBODY;
CARMUSTINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYTARABINE;
CYTOTOXIC AGENT;
ETOPOSIDE;
GOLD;
MELPHALAN;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ALLOTRANSPLANTATION;
APLASTIC ANEMIA;
AUTOIMMUNE DISEASE;
AUTOTRANSPLANTATION;
BONE MARROW SUPPRESSION;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE MODEL;
DOSE RESPONSE;
DRUG MEGADOSE;
GRAFT FAILURE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNE SYSTEM;
IMMUNOSUPPRESSIVE TREATMENT;
LIFE EXPECTANCY;
LONG TERM CARE;
LYMPHOCYTE;
MALIGNANT NEOPLASTIC DISEASE;
MORBIDITY;
MORTALITY;
MULTIPLE SCLEROSIS;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PATHOPHYSIOLOGY;
PILOT STUDY;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
SYSTEMIC SCLEROSIS;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VALIDATION PROCESS;
WHOLE BODY RADIATION;
ARTHRITIS, RHEUMATOID;
AUTOIMMUNE DISEASES;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
SURVIVAL RATE;
|
EID: 0036278358
PISSN: 15651088
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (25)
|